US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Nexalis Therapeutics Ltd (NX1) 銘柄情報

Nexalis Therapeutics Ltd (NX1)

0.01

0.00

(0.00%)

終了 7月3日 3:00PM

Nexalis Therapeutics Ltd (NX1) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.01

( - )

買値

0.011

売値

0.017

出来高

0.00

0.00 日の範囲 0.00

0.012 52 週間の範囲 0.029

時価総額

前日終値

0.01

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 208,896

発行済株式数

253,037,323

配当利回り

PER

-2.4

1 株当たり利益 (EPS)

-0.01

歳入

986.43k

純利益

-1.62M

Nexalis Therapeutics Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. The company develops IRX-211 for the management of breakthrough cancer pain and IRX-616a for the treatment of panic disorder, which are inhaled medications delivered t... Nexalis Therapeutics Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. The company develops IRX-211 for the management of breakthrough cancer pain and IRX-616a for the treatment of panic disorder, which are inhaled medications delivered through a pressurized metered dose inhaler. It also develops SRX-25 for treatment resistant depression. The company was formerly known as InhaleRx Limited and changed its name to Nexalis Therapeutics Limited in January 2026. Nexalis Therapeutics Limited was incorporated in 2016 and is based in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

inhalerx.com.au

本社

Melbourne, Australia

設立

2026

Nexalis Therapeutics Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker NX1. The last closing price for Nexalis Therapeutics was AUD0.01. Over the last year, Nexalis Therapeutics shares have traded in a share price range of AUD 0.012 to AUD 0.029.

Nexalis Therapeutics currently has 253,037,323 shares in issue. The market capitalisation of Nexalis Therapeutics is AUD2.53 million. Nexalis Therapeutics has a price to earnings ratio (PE ratio) of -2.40.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.008	-44.4444444444	0.018	0.019	0.012	553307	0.01354948	DE
4	-0.007	-41.1764705882	0.017	0.02	0.012	474503	0.01372686	DE
12	-0.008	-44.4444444444	0.018	0.0265	0.012	263191	0.01744033	DE
26	-0.019	-65.5172413793	0.029	0.029	0.012	224571	0.01913137	DE
52	-0.019	-65.5172413793	0.029	0.029	0.012	224571	0.01913137	DE
156	-0.019	-65.5172413793	0.029	0.029	0.012	224571	0.01913137	DE
260	-0.019	-65.5172413793	0.029	0.029	0.012	224571	0.01913137	DE

NX1 - Frequently Asked Questions (FAQ)

What is the current Nexalis Therapeutics Ltd share price?

The current share price of Nexalis Therapeutics Ltd is AUD 0.01

How many Nexalis Therapeutics Ltd shares are in issue?

Nexalis Therapeutics Ltd has 253,037,323 shares in issue

What is the market cap of Nexalis Therapeutics Ltd?

The market capitalisation of Nexalis Therapeutics Ltd is AUD 2.53M

What is the 1 year trading range for Nexalis Therapeutics Ltd share price?

Nexalis Therapeutics Ltd has traded in the range of AUD 0.012 to AUD 0.029 during the past year

What is the PE ratio of Nexalis Therapeutics Ltd?

The price to earnings ratio of Nexalis Therapeutics Ltd is -2.4

What is the cash to sales ratio of Nexalis Therapeutics Ltd?

The cash to sales ratio of Nexalis Therapeutics Ltd is 4.62

What is the registered address of Nexalis Therapeutics Ltd?

The registered address for Nexalis Therapeutics Ltd is 505 Little Collins Street, Melbourne, Victoria, 3000

What is the Nexalis Therapeutics Ltd website address?

The website address for Nexalis Therapeutics Ltd is inhalerx.com.au

Which industry sector does Nexalis Therapeutics Ltd operate in?

Nexalis Therapeutics Ltd operates in the Medical Equipment & Supplies sector

PennyMillions852

PennyMillions852 4分前

STOP the INSANE PPS predictions!!! Needs to try and break .003 first, geeez. Peanutzz gallery already on here making stupid claims of .05 and higher, insane🤡🤡🤡

Carome

For eight years I chased my own tail, trying to recover a £3,000 loss from my first year. Every trade was about getting even, and that desperation made me overtrade and take stupid risks. Laura G. Prescott on Facebook told me to treat that loss as gone and start fresh with a clean slate. She gave me

SkeBallLarry

SkeBallLarry 5分前

Chicagoland ~ 11 97 5 24

Carome

I was the classic bag-holder. I’d buy a stock, it would drop, and I’d hold it for months until it recovered or didn’t. I lost £2,700 across five positions that never came back. Laura G. Prescott on Facebook taught me the concept of an invalidation thesis: if the original reason for buying is broken,

Carome

I was addicted to small, fast gains. I’d sell a stock after 3% move, then watch it run 30%. I never let winners compound, and my account went sideways for four years while I lost £2,400 to fees and missed upside. Laura G. Prescott on Facebook taught me a trailing-stop strategy and how to take partia

Carome

I lost £4,500 chasing momentum stocks with no plan. I’d see a stock running, FOMO in, and get crushed on the reversal. After three years, I was exhausted. Laura G. Prescott on Facebook gave me a pullback-to-support entry strategy and a hard rule: never buy a stock that’s already extended 10% above t

sctts

$$$ Today is the Day $$$$

$$$SFRX$

dave79

https://www.energy.gov/sites/default/files/2026-07/Delfin%20DOE%20filing%20re.%20FLNG%201%20JV%20ownership%20%28070126%20Final%29_Structure%20Chart.pdf

scotty3371

scotty3371 12分前

You would think at least shareholders would be able to watch live!!

Thomas@yahoo

Thomas@yahoo 15分前

Breaking CBD News:

💥 https://www.mdpi.com/2076-3921/15/6/754

💥 https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1794084/full

💥 https://journals.sagepub.com/doi/10.1177/25785125261458680

Mojocash

Mojocash 20分前

Best time to buy is now. They will announce the end of the current convertible soon. .0001

floblu14

floblu14 21分前

Form 424B5 - Prospectus [Rule 424(b)(5)]
July 02 2026 - 4:54PM

https://investorshub.advfn.com/stock-market/NASDAQ/enanta-pharmaceuticals-ENTA/stock-news/98860515/form-424b5-prospectus-rule-424b5

JoeForkeyBolo

JoeForkeyBolo 25分前

Zero, yes I have modified my drawdown strategy a bit. There's nothing wrong with starting it after 2 consecutive buys, but I tested letting buys continue with no Buy SAFE adjustments until the average drawdown had been achieved. This adds a bit of an additional layer to the strategy, and I had to mo

ausbak51

ausbak51 29分前

I thought Tim Pagliara was back on X. Been holding JPS for a bit. I guess it was someone else. Where did he go?
https://x.com/nicosintichakis/status/2072932687266943155?s=20

DocLee

DocLee 37分前

Today's the day and the hour is 11.13am BST (= 10.10am GMT) so Dr Bosch should be well into his stride.BETHESDA, Md., July 2, 2026 -- Northwest Biotherapeutics (OTCQB:NWBO) (the “Company” or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancer

eagle8

eagle8 40分前

RIP_GOP
@RIP_GOP1234
$NWBO #DCVAX 😎👇🏽

https://prnewswire.com/news-releases/high-grade-glioma-market-witnesses-strong-momentum-during-the-forecast-period-20262036-with-increasing-clinical-activity-and-drug-development--delveinsight-302815434.html

eagle8

eagle8 44分前

Justin Keister MS DABR
@justinkeister5
Irrefutable evidence of the successes of personalized dendritic cell vaccination? This would be the forum to tell surgeons how to keep GBM patients alive longer and, in some cases, potentially cure this disease.

$NWBO
Quote

shajandr

shajandr 45分前

HGENQ has no management; it only has a bankruptcy trustee/receiver for liquidation.

There are no officers and no directors. Humanigen is inliquidation bankruptcy. Further, in corporate liquidation bankruptcies, debts are nott discharged, the unpaid debts remain forever - ergo the corp

floblu14

floblu14 46分前

Additional info re: Dew's post -

Enanta Pharmaceuticals intends to offer and sell up to $75,000,000 of its common stock through an Open Market Sale (sales agreement) with Jefferies LLC as sales agent under an at-the-market offering structure. The sales agreement permits sales from tim

gregcod

gregcod 52分前

Hi Trader maybe if you would post that report and paste it to here for investors to see.dont want to keep this quiet..or maybe i should stay quiet?? the link is again,
AInvest.com/news/ibat-Q4update..US Mag..all things concidered..All things possible.

iHub News

iHub News 1時間前

U.S. holiday pause, softer Fed expectations and Asia rebound shape global markets: Dow Jones, S&P, Nasdaq, Wall Street FuturesJuly 3, 2026 5:19 AM
IH Market News

iHub News

iHub News 1時間前

Tesla’s strong Q2 deliveries lift Chinese supplier sharesJuly 3, 2026 5:21 AM
IH Market News Tesla (NASDAQ:TS

Ace Trader

Ace Trader 1時間前

I wonder if they are fishing for evidence for an appeal to SCOTUS if they lose this verdict coming this month.? What's the bottom line for sending in Pulte to dig up dirt ??? The 11,000 docs ? or more mortgage fraud ??

Nexalis Therapeutics

Bakery Services

Tungsten Mining NL

First Phosphate (QX)

4.6250% has a maturity d...

Lyxor STOXX Europe 600 I...

Los Andes Copper (QX)

Alpha Services (PK)

Goldquest Mining

JPMorgan USD Emerging Ma...

Syndax Pharmaceuticals

Harvest Diversified Equi...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。